The Predictive Performance of Risk Scores for the Outcome of COVID-19 in a 2-Year Swiss Cohort.

Maria Boesing, Giorgia L��thi-Corridori, David B��ttiker, Mireille Hunziker, Fabienne Jaun, Ugne Vaskyte, Michael Br��ndle, J��rg D Leuppi
Author Information
  1. Maria Boesing: University Institute of Internal Medicine, Cantonal Hospital Baselland, 4410 Liestal, Switzerland. ORCID
  2. Giorgia L��thi-Corridori: University Institute of Internal Medicine, Cantonal Hospital Baselland, 4410 Liestal, Switzerland.
  3. David B��ttiker: University Institute of Internal Medicine, Cantonal Hospital Baselland, 4410 Liestal, Switzerland.
  4. Mireille Hunziker: University Institute of Internal Medicine, Cantonal Hospital Baselland, 4410 Liestal, Switzerland.
  5. Fabienne Jaun: University Institute of Internal Medicine, Cantonal Hospital Baselland, 4410 Liestal, Switzerland. ORCID
  6. Ugne Vaskyte: University Institute of Internal Medicine, Cantonal Hospital Baselland, 4410 Liestal, Switzerland.
  7. Michael Br��ndle: Department of Internal Medicine, Cantonal Hospital Sankt Gallen, 9000 Sankt Gallen, Switzerland.
  8. J��rg D Leuppi: University Institute of Internal Medicine, Cantonal Hospital Baselland, 4410 Liestal, Switzerland. ORCID

Abstract

Various scoring systems are available for COVID-19 risk stratification. This study aimed to validate their performance in predicting severe COVID-19 course in a large, heterogeneous Swiss cohort. Scores like the National Early Warning Score (NEWS), CURB-65, 4C mortality score (4C), Spanish Society of Infectious Diseases and Clinical Microbiology score (COVID-SEIMC), and COVID Intubation Risk Score (COVID-IRS) were assessed in patients hospitalized for COVID-19 in 2020 and 2021. Predictive accuracy for severe course (defined as all-cause in-hospital death or invasive mechanical ventilation (IMV)) was evaluated using receiver operating characteristic curves and the area under the curve (AUC). The new 'COVID-COMBI' score, combining parameters from the top two scores, was also validated. This study included 1,051 patients (mean age 65 years, 60% male), with 162 (15%) experiencing severe course. Among the established scores, 4C had the best accuracy for predicting severe course (AUC 0.76), followed by COVID-IRS (AUC 0.72). COVID-COMBI showed significantly higher accuracy than all established scores (AUC 0.79, = 0.001). For predicting in-hospital death, 4C performed best (AUC 0.83), and, for IMV, COVID-IRS performed best (AUC 0.78). The 4C and COVID-IRS scores were robust predictors of severe COVID-19 course, while the new COVID-COMBI showed significantly improved accuracy but requires further validation.

Keywords

References

  1. Indian J Crit Care Med. 2020 Nov;24(11):1143-1144 [PMID: 33384528]
  2. Thorax. 2021 Sep;76(9):920-929 [PMID: 33632764]
  3. Ther Adv Respir Dis. 2020 Jan-Dec;14:1753466620963017 [PMID: 33054630]
  4. Thorax. 2003 May;58(5):377-82 [PMID: 12728155]
  5. J Clin Med. 2023 Jun 15;12(12): [PMID: 37373748]
  6. Eur Respir J. 2020 Sep 10;56(3): [PMID: 32675205]
  7. J Pers Med. 2022 May 26;12(6): [PMID: 35743663]
  8. PLoS One. 2021 Oct 1;16(10):e0257641 [PMID: 34597325]
  9. Wien Med Wochenschr. 2022 Jun;172(9-10):211-219 [PMID: 34185216]
  10. PLoS One. 2021 Apr 5;16(4):e0248357 [PMID: 33819261]
  11. Rev Med Virol. 2020 Nov;30(6):1-9 [PMID: 32845568]
  12. BMJ. 2020 Sep 9;370:m3339 [PMID: 32907855]
  13. Diagnostics (Basel). 2022 May 03;12(5): [PMID: 35626285]
  14. Lancet. 2020 Feb 8;395(10222):401 [PMID: 32035538]
  15. BMC Infect Dis. 2024 Feb 23;24(1):254 [PMID: 38395855]
  16. Obes Rev. 2023 Sep;24(9):e13591 [PMID: 37341377]
  17. Chest. 2022 Apr;161(4):927-936 [PMID: 34740594]
  18. Lancet Reg Health Eur. 2024 Feb 02;38:100855 [PMID: 38476753]
  19. Expert Rev Respir Med. 2021 Aug;15(8):1013-1023 [PMID: 33847219]
  20. BMJ. 2020 Mar 12;368:m1036 [PMID: 32165426]
  21. Radiology. 2023 Feb;306(2):e222462 [PMID: 36625747]
  22. Am J Emerg Med. 2022 Apr;54:46-57 [PMID: 35121478]
  23. Pulmonology. 2022 May-Jun;28(3):173-180 [PMID: 33500220]
  24. PLoS One. 2020 Sep 24;15(9):e0239519 [PMID: 32970733]
  25. J Gen Intern Med. 2021 May;36(5):1338-1345 [PMID: 33575909]
  26. Intensive Care Med. 2020 Jan;46(1):36-45 [PMID: 31659387]
  27. Intensive Care Med. 2021 Dec;47(12):1426-1439 [PMID: 34585270]
  28. J Anesth Analg Crit Care. 2021 Nov 27;1(1):19 [PMID: 37386623]
  29. Acta Biomed. 2020 Mar 19;91(1):157-160 [PMID: 32191675]
  30. BMC Palliat Care. 2024 Feb 15;23(1):42 [PMID: 38355511]
  31. Front Med (Lausanne). 2023 Feb 08;10:1121465 [PMID: 36844229]
  32. Eur Respir J. 2020 May 14;55(5): [PMID: 32217650]
  33. Resuscitation. 2021 Feb;159:150-157 [PMID: 33176170]
  34. JAMA Intern Med. 2020 Jul 1;180(7):934-943 [PMID: 32167524]
  35. Pneumonia (Nathan). 2021 Dec 6;13(1):14 [PMID: 34872623]
  36. Respir Care. 2018 Dec;63(12):1528-1534 [PMID: 30467224]
  37. Biometrics. 1988 Sep;44(3):837-45 [PMID: 3203132]
  38. BMC Infect Dis. 2021 Aug 21;21(1):855 [PMID: 34418980]
  39. JAMA. 2016 Feb 23;315(8):762-74 [PMID: 26903335]
  40. Sci Rep. 2021 Feb 3;11(1):2933 [PMID: 33536460]
  41. Inform Med Unlocked. 2022;28:100825 [PMID: 34977330]
  42. Virology. 2020 Dec;551:1-9 [PMID: 33010669]
  43. Resuscitation. 2021 May;162:441-442 [PMID: 33600855]
  44. J Emerg Med. 2023 Dec;65(6):e487-e494 [PMID: 37838495]

Grants

  1. YTCR Beginner Grant 18/20/Swiss Academy of Medical Sciences

Word Cloud

Created with Highcharts 10.0.0COVID-19severecourseAUC04CscoreCOVID-IRSaccuracyscorespredictingin-hospitaldeathbestCOVID-COMBIriskstudySwissScoresScoreRiskpatientsPredictiveventilationIMVnewestablishedshowedsignificantlyperformedVariousscoringsystemsavailablestratificationaimedvalidateperformancelargeheterogeneouscohortlikeNationalEarlyWarningNEWSCURB-65mortalitySpanishSocietyInfectiousDiseasesClinicalMicrobiologyCOVID-SEIMCCOVIDIntubationassessedhospitalized20202021definedall-causeinvasivemechanicalevaluatedusingreceiveroperatingcharacteristiccurvesareacurve'COVID-COMBI'combiningparameterstoptwoalsovalidatedincluded1051meanage65years60%male16215%experiencingAmong76followed72higher79=0018378robustpredictorsimprovedrequiresvalidationPerformanceOutcome2-YearCohortSARS-CoV-2outcome

Similar Articles

Cited By (1)